Adheron Therapeutics
Berkeley, US · Delaware corporation
Founders & leadership
BB
Bob BalteraExecutive Chairman.
CT
Chris ThomajanChief Financial Officer.
HK
Hari KumarChief Executive Officer.
Board
DO
Doug OnsiBoard director
RD
Rajeev DadooBoard director
IP
Isai PeimerBoard director
RL
Ron LauferBoard director
DC
David CastaldiBoard director
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2015
▶$1.5MraisedJul 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedJul 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bob BalteraDirector, Executive Officer
- Doug OnsiDirector
- Rajeev DadooDirector
- Chris ThomajanExecutive Officer
- Isai PeimerDirector
- Ron LauferDirector
- Hari KumarExecutive Officer, Director
- David CastaldiDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Adheron Therapeutics raised?
- Adheron Therapeutics has disclosed $1.5M raised across 1 round.
- Where is Adheron Therapeutics headquartered?
- Adheron Therapeutics is headquartered in Berkeley, US.